
Start-Ups Swimming ...


| Price and Volume | |
|---|---|
| Recent Price | 0.25 |
| 52 Week High | 0.41 |
| 52 Week Low | 0.17 |
| Avg. Daily Vol. (Mil) | 0.06 |
| Beta (3 year) | 1.59 |
| Share Related Items | |
| Mkt Cap (Mil) | 40.13 |
| Shares Out (Mil) | 163.79 |
| Float (Mil) | 0.00 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 0.90 |
| Current Ratio | 1.10 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | n.a. |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 0.00 |
| Price/Cash Flow | -1.90 |
| Per Share Data | |
| Earnings | -0.13 |
| Sales | 0.00 |
| Book Value | 0.00 |
| Cash Flow | -0.13 |
| Business Summary | |
|---|---|
| Sophiris Bio Inc is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of urological diseases. It is currently developing PRX302 for treatment of the symptoms of benign prostatic hyperplasia. | |
| General Information | |
| 1258 Prospect Street
La Jolla, CA 92037 |
|
| www.sophirisbio.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 9 | |
| CEO: Randall E. Woods | |
| Short Interest | |
| Current Month (Mil) | 0.00 |
| Previous Month (Mil) | 0.00 |
| Short Interest Ratio (Days) | 0.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -185.90 |
| Return on Investments | -241.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |